These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7073945)

  • 1. Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo.
    Richardson VJ; Ryman BE
    Br J Cancer; 1982 Apr; 45(4):552-8. PubMed ID: 7073945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.
    Richardson VJ; Curt GA; Ryman BE
    Br J Cancer; 1982 Apr; 45(4):559-64. PubMed ID: 7073946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to overcome in vivo anti-cancer drug resistance.
    Rustum YM; Radel S; Campbell J; Mayhew E
    Prog Clin Biol Res; 1986; 223():187-202. PubMed ID: 3492716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Zühlsdorf M; Rolf C; Reuter C; Kewer U; Uhrmeister C; Wörmann B; Büchner T
    Leukemia; 1992 Dec; 6(12):1273-80. PubMed ID: 1453772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
    Someya H; Waud WR; Parker WB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis.
    Williams AS; Camilleri JP; Amos N; Williams BD
    Clin Exp Immunol; 1995 Dec; 102(3):560-5. PubMed ID: 8536373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Lewis lung carcinoma and hepatoma ascites treatment by combination of liposome chemotherapy and non-specific immunotherapy.
    Patel KR; Baldeschwieler JD
    Int J Cancer; 1984 Nov; 34(5):717-23. PubMed ID: 6389375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.
    Matthay KK; Heath TD; Papahadjopoulos D
    Cancer Res; 1984 May; 44(5):1880-6. PubMed ID: 6713389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.
    Alekseeva AA; Moiseeva EV; Onishchenko NR; Boldyrev IA; Singin AS; Budko AP; Shprakh ZS; Molotkovsky JG; Vodovozova EL
    Int J Nanomedicine; 2017; 12():3735-3749. PubMed ID: 28553111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.
    Williams AS; Jones SG; Goodfellow RM; Amos N; Williams BD
    Br J Pharmacol; 1999 Sep; 128(1):234-40. PubMed ID: 10498857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro uptake and therapeutic application of liposome-encapsulated methotrexate in mouse hepatoma 129.
    Patel KR; Jonah MM; Rahman YE
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):833-43. PubMed ID: 6891330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
    Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of antitumor drug to bladder cancer by use of phase transition liposomes and hyperthermia.
    Tacker JR; Anderson RU
    J Urol; 1982 Jun; 127(6):1211-4. PubMed ID: 7087041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E; Eiferman F
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal chemotherapy with antineoplastic agents in children.
    Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
    Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model.
    Gabizon A; Goren D; Fuks Z; Meshorer A; Barenholz Y
    Br J Cancer; 1985 May; 51(5):681-9. PubMed ID: 3994911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.